which semaglutide is fda approved approves Ozempic® (semaglutide) as the only GLP-1 RA to reduce the risk of worsening kidney disease and cardiovascular death in adults with type 2 diabetes and chronic kidney disease FDA Approves Semaglutide for New

The study followed nearly 100,000 individuals using Swedish national registers from 2009 to 2022, including more than 20,000 people who used GLP-1 medications

GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and the dual GIP/GLP-1 agonist tirzepatide carry the clinical evidence: STEP for semaglutide ( The New England Journal of Medicine , 2021), SURMOUNT for tirzepatide (NEJM, 2022), and SURMOUNT-OSA for tirzepatide in obstructive sleep apnea (NEJM, 2024)

Like GLP-1 hormones, GIP hormones are triggered when you eat and increase insulin production

It is NOT a stimulant

Pleasant flavour Daily dotox and d anti-oxidant

Direct answer: Tirzepatide targets two hormone pathways, which may create stronger appetite control for some people